Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision label advances from v3.7.1 to v3.7.2.SummaryDifference0.8%

- Check45 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a new Revision: v3.7.0 entry to the history and removed the previous Revision: v3.6.6 entry, reflecting an update to the study record's version history.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry v3.6.6 was added to the record history, replacing the previous v3.6.5, signaling a minor site release update.SummaryDifference0.1%

Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.